Sitemap
November 08, 2016 Articles
Filter by Available Specialty
- ‘3+0’ schedule with PCV7 impacts IPD more than PCV13
- ALKS 5461 effective, safe for treatment-resistant MDD
- Analysis of the Canadian hypertension guidelines and the impact on upcoming recommendations
- Antenatal corticosteroids reduce respiratory distress syndrome in certain infants
- AUVI-Q to return in early 2017
- Avoid exaggeration in facial augmentation while creating natural symmetry
- Binge-eating risk increased with eating in the absence of hunger during childhood
- Cannabis potency may influence severity of dependence
- Carfilzomib-based triplet improves quality of life in relapsed multiple myeloma
- Conjugated linoleic acid improves insulin sensitivity
- Delayed HBV, HCV diagnosis may increase advanced liver disease
- Development of cholesterol efflux promoter discontinued
- Different neuromodulator filler products offer varied outcomes
- Endocrine disorders prevalent among childhood brain tumor survivors
- EOS Imaging receives FDA 510(k) clearance to market 3-D planning software for TKA
- FDA approves IND for elafibranor for primary biliary cholangitis
- FDA grants clearance to Syneron Candela's microneedling device for appearance of cellulite
- Fred Hutchinson Cancer Research Center names executive VP
- High failure rate found with use of modular-neck femoral stem in THA
- HIV-RNA common in spinal fluid of patients receiving ART
- Hypertensive disorders during pregnancy: A window into future CV risk
- Hypopituitarism, diabetes insipidus associated with decreased oxytocin, empathic ability
- Low FODMAP diet improves IBS-D symptoms
- Maternal B12 levels associated with leptin levels in placental tissue, cord blood
- Maternal return-to-work timing linked to child’s weight gain
- New questionnaire more accurately identified rheumatic disease
- One in five C. diff patients re-hospitalized within 30 days
- PrEP regimens containing Selzentry safe, well-tolerated compared with Truvada
- Prescription subsidies reduce racial disparities in hormone therapy persistence
- pSivida brings on Deb Jorn as executive vice president of corporate and commercial development
- Quantitative MRI study finds chondroitin sulfate superior to celecoxib for knee cartilage loss
- Quantity limits for blood glucose test strips reduce costs
- Spark Therapeutics reports $32.6 million loss in third quarter
- Study challenges the causal interpretation of childhood abuse, cognitive function
- Study finds brain changes may still occur in youth football players exposed to sub-concussive impact
- SVOne comparable to traditional refractive error measures
- Tailored dose-dense therapy fails to improve RFS in early breast cancer
- The 5 most-viewed articles by Cardiology Today’s Intervention readers in October
- Trial Scorecard: CALIBER
- Trial Scorecard: DANISH
- Trial Scorecard: DISRUPT PAD
- Trial Scorecard: ESPRIT I
- Trial Scorecard: INTERHEART
- Trial Scorecard: ROPAC
- Trial Scorecard: TACTICS-HF
- Trial Scorecard: TARIFF
- Triggered vaccination campaigns could reduce size, severity of measles outbreaks
- USPSTF colorectal cancer screening guidelines challenged
- Venomous copperhead, exotic snakebites on the rise among children
- VIDEO: PRK an acceptable option for thin corneas
- VIDEO: Treat astigmatism in glaucoma patients at time of cataract surgery
- VIDEO: Trial of embolic protection during TAVR confirms need for further study
- Wearable technologies may transform patient care, clinical research